These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25466635)

  • 1. MSP: an emerging player in metabolic syndrome.
    Li J; Chanda D; Shiri-Sverdlov R; Neumann D
    Cytokine Growth Factor Rev; 2015 Feb; 26(1):75-82. PubMed ID: 25466635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide.
    Morrison AC; Wilson CB; Ray M; Correll PH
    J Immunol; 2004 Feb; 172(3):1825-32. PubMed ID: 14734766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells.
    Feres KJ; Ischenko I; Hayman MJ
    Oncogene; 2009 Jan; 28(2):279-88. PubMed ID: 18836480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MSP-RON signalling in cancer: pathogenesis and therapeutic potential.
    Yao HP; Zhou YQ; Zhang R; Wang MH
    Nat Rev Cancer; 2013 Jul; 13(7):466-81. PubMed ID: 23792360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage stimulating protein preserves blood brain barrier integrity after intracerebral hemorrhage through recepteur d'origine nantais dependent GAB1/Src/β-catenin pathway activation in a mouse model.
    Lu T; Wang Z; Prativa S; Xu Y; Wang T; Zhang Y; Yu L; Xu N; Tang J; You W; Chen G; Zhang JH
    J Neurochem; 2019 Jan; 148(1):114-126. PubMed ID: 30380151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MSP-induced RON activation upregulates uPAR expression and cell invasiveness via MAPK, AP-1 and NF-κB signals in gastric cancer cells.
    Park JS; Park JH; Khoi PN; Joo YE; Jung YD
    Carcinogenesis; 2011 Feb; 32(2):175-81. PubMed ID: 21081472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage-stimulating protein and RON receptor tyrosine kinase: potential regulators of macrophage inflammatory activities.
    Wang MH; Zhou YQ; Chen YQ
    Scand J Immunol; 2002 Dec; 56(6):545-53. PubMed ID: 12472665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MSP-RON Pathway: Potential Regulator of Inflammation and Innate Immunity.
    Huang L; Fang X; Shi D; Yao S; Wu W; Fang Q; Yao H
    Front Immunol; 2020; 11():569082. PubMed ID: 33117355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for the binding specificity of human Recepteur d'Origine Nantais (RON) receptor tyrosine kinase to macrophage-stimulating protein.
    Chao KL; Gorlatova NV; Eisenstein E; Herzberg O
    J Biol Chem; 2014 Oct; 289(43):29948-60. PubMed ID: 25193665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional consequences of the macrophage stimulating protein 689C inflammatory bowel disease risk allele.
    Kauder SE; Santell L; Mai E; Wright LY; Luis E; N'Diaye EN; Lutman J; Ratti N; Sa SM; Maun HR; Stefanich E; Gonzalez LC; Graham RR; Diehl L; Faubion WA; Keir ME; Young J; Chaudhuri A; Lazarus RA; Egen JG
    PLoS One; 2013; 8(12):e83958. PubMed ID: 24409221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MSP-RON axis stimulates cancer cell growth in models of triple negative breast cancer.
    Millar R; Kilbey A; Remak SJ; Severson TM; Dhayade S; Sandilands E; Foster K; Bryant DM; Blyth K; Coffelt SB
    Mol Oncol; 2020 Aug; 14(8):1868-1880. PubMed ID: 32484599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage-stimulating protein attenuates gentamicin-induced inflammation and apoptosis in human renal proximal tubular epithelial cells.
    Lee KE; Kim EY; Kim CS; Choi JS; Bae EH; Ma SK; Kim KK; Lee JU; Kim SW
    Biochem Biophys Res Commun; 2013 May; 434(3):527-33. PubMed ID: 23583394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency in macrophage-stimulating protein results in spontaneous intestinal inflammation and increased susceptibility toward epithelial damage in zebrafish.
    Witte M; Huitema LF; Nieuwenhuis EE; Brugman S
    Zebrafish; 2014 Dec; 11(6):542-50. PubMed ID: 25353089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase.
    Wang MH; Wang D; Chen YQ
    Carcinogenesis; 2003 Aug; 24(8):1291-300. PubMed ID: 12807733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between RON receptor tyrosine kinase and other transmembrane receptors.
    Danilkovitch-Miagkova A; Leonard EJ
    Histol Histopathol; 2001 Apr; 16(2):623-31. PubMed ID: 11332718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers.
    Wang MH; Yao HP; Zhou YQ
    Acta Pharmacol Sin; 2006 Jun; 27(6):641-50. PubMed ID: 16723080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-stimulating protein attenuates hydrogen peroxide-induced apoptosis in human renal HK-2 cells.
    Lee KE; Kim EY; Kim CS; Choi JS; Bae EH; Ma SK; Park JS; Jung YD; Kim SH; Lee JU; Kim SW
    Eur J Pharmacol; 2013 Sep; 715(1-3):304-11. PubMed ID: 23726950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MSP is a negative regulator of inflammation and lipogenesis in ex vivo models of non-alcoholic steatohepatitis.
    Chanda D; Li J; Oligschlaeger Y; Jeurissen ML; Houben T; Walenbergh SM; Shiri-Sverdlov R; Neumann D
    Exp Mol Med; 2016 Sep; 48(9):e258. PubMed ID: 27609031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine kinase receptor RON and its ligand MSP in Merkel cell carcinoma.
    Nagahama J; Daa T; Yada N; Kashima K; Fujiwara S; Saikawa T; Yokoyama S
    Pathol Res Pract; 2011 Aug; 207(8):463-7. PubMed ID: 21723047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression.
    Kretschmann KL; Eyob H; Buys SS; Welm AL
    Curr Drug Targets; 2010 Sep; 11(9):1157-68. PubMed ID: 20545605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.